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English Abstract
Introduction: The importance of treating cancer as an important
disease has attracted many scientists and researchers. The serious problem
with this disease is that many cancers still do not respond to common
treatments like chemotherapy and other cancers that initially respond
become resistant. So, chemotherapy with the current drugs is not enough to
treat some cancers and it is necessary to discover novel and more efficient
compounds with stronger anti-cancer activity.
Development of new molecules based on a previously known
structure is among accepted methods from the pharmaceutical chemist's
point of view. One of these structures is xanthine derivatives. In the present
study, further development of theobromine derivatives and the production
of a number of new derivatives of Nr- (phenoxyethyl) theobromine have
been investigated. Subsequently, based on the previously reported
compounds that have a structure similar to these compounds, the ability to
interact with the enzymes of adenosine deaminase, ecto -5'-nucleotidas, and
phosphodiesteras, which play a role in the treatment of cancer, have been
studied by molecular docking method. Finally, the cytotoxicity of the
synthesized compounds against four cell lines of A549, MCF7, HEPG2,
andPCl2 was performed.
Methods: At first, compounds 2,3 and (5a-51) were synthesized in the
laboratory.
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Determination of the structure of synthesized compounds was
performed by IR spectra, 'F[.IMR spectra and some of them were also
characterizedby t'CNMR. The structure of our compounds was drawn in
two-dimensional format using ChemDraw software and their enerry was
optimized using OpenBabel software and saved as a ligand with pe
extension for use by AutoDock software. In the next step, the relmed
enzyme file contain Phosphodiesterase, ecto-5'-nucleotidase and Adenosirc
deaminase was obtained from the Protein Data Bank site. After m-kirE
necessary edits on the receptor, they were separately assigned to eachoffu
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ligands that were designed in the previous step by AutoDock 4.2 software.
Afterwards and in order to evaluate the cytotoxic effect of the synthesized
compounds the mentioned four cell lines MTT test was performed.
Results: The results of IR, 1HNMR and 
"CNMR spectra showed that
all derivatives were successfully synthesized in the laboratory they also
showed an acceptable binding energy in molecular modeling method. The
results of cytotoxicity assay showed that the greatest effect of cell
cytotoxicity occurred on the cell line of A54g (viability percent 40.08
compound 5e) and MCFT (viability percent 41.37 compound 5d). The
calculated IC5s was found to be 86.65 pM against cell line of 4549.
Discussion and Conclusion: The results of molecular docking
showed an acceptable binding energy against the enzyme ecto-S'-
nucleotidase. Among the synthesized derivatives, compound 5a with the
lowest AG was chosen as the best inhibitor of this enzyme. The high effects
of cell toxicity at various concentrations of synthesized compounds on
MCFT A549 cell lines were also observed.
Keywords: Theobromine derivatives, Molecular modeling, Cytotoxicity
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